Investigation of a High-Dose pH-Dependent-Release Mesalazine on the Induction of Remission in Active Crohn’s Disease
Crossref DOI link: https://doi.org/10.1007/s40268-015-0113-9
Published Online: 2016-02-16
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Suzuki, Yasuo
Iida, Mitsuo
Ito, Hiroaki
Tachikawa, Naoto
Hibi, Toshifumi
Funding for this research was provided by:
Zeria Pharmaceutical Co., Ltd.
License valid from 2016-02-16